Maximus Stock - Analyst views and background on the outsourcing specialist

Maximus stock draws steady interest as a US government services outsourcer. With no fresh ad-hoc news, the focus shifts to current analyst opinions, valuation context and the role its core Medicaid and Medicare programs play in long-term demand.

Edited by ad hoc news Background & Management Desk. Verified prior to publication on 06/21/2026, 18:20 UTC. Details in the imprint.

Maximus (US5779331041) operates as a major outsourced service provider for US public-sector health and human services programs. With no new earnings release, SEC filing or rating change reported by leading wires today, the spotlight turns to existing analyst views and the company’s structural positioning in government outsourcing.

What recent filings show

Maximus most recently updated investors with fiscal 2024 guidance and performance data in its second-quarter materials for the period ended 03/31/2024, highlighting growth in its US Federal Services and US Services segments. The company reported revenue of about $1.35 billion for that quarter. IR quarterly results

Management has emphasized contract wins in Medicare, Medicaid and related eligibility and enrollment work, which underpin a sizeable multiyear backlog. In earlier commentary, executives pointed to robust demand for complex case management and call-center operations for US government agencies.

Analyst sentiment and valuation lens

Sell-side coverage on Maximus remains relatively limited compared with larger outsourcing peers, but available consensus data indicate a mixed stance, with a combination of Buy and Hold ratings clustered around a mid-teens earnings multiple. Public aggregation platforms show price targets that imply moderate upside from recent trading levels. MarketWatch analyst overview

Analysts generally cite the company’s exposure to long-term US government contracts as a stabilizing factor, while flagging risks from periodic contract recompetes and changing policy priorities at federal and state levels. Margins in certain state-level programs have come under scrutiny in past quarters when volumes or staffing costs shifted.

Background on operations and management

Maximus has built its business model around outsourcing administrative and contact-center tasks for public health and social services, leaving government clients to focus on policy and oversight. The group manages large-scale call centers, eligibility verification and case-handling platforms for beneficiaries.

Over the years, Maximus has complemented organic growth with acquisitions to deepen capabilities in clinical assessments, digital engagement and analytics. Leadership has repeatedly stressed investments in technology to streamline workflows, including automated document processing and digital self-service options for beneficiaries.

How the company makes money

Maximus primarily generates revenue from multi-year contracts with US federal and state agencies, often structured as cost-plus, fixed-price or performance-based agreements. Key programs span Medicaid, the Children’s Health Insurance Program, Medicare and various employment and child-support initiatives.

The company typically earns fees tied to transaction volumes, service levels or specific performance metrics, such as call handling times or case resolution benchmarks. This structure can provide relatively predictable cash flows, though earnings may fluctuate when large contracts start, end or are rebid.

Where the stock trades today

The shares of Maximus (US5779331041) trade on the New York Stock Exchange under the ticker MMS, recently quoted around the mid-$80 range in US dollars. Intraday liquidity reflects its status as a mid-cap US outsourcing stock.

Key facts on Maximus stock

• Company: Maximus Inc.
• ISIN: US5779331041
• WKN: 892387
• Ticker: MMS
• Venue: NYSE
• Price (as of 06/21/2026, 18:15 UTC): 84.50 USD
• Market cap: 5,180,000,000 USD (as of 06/21/2026)
• Sector / Industry: Professional Services / Business Process Outsourcing
• Index membership: included in selected US mid-cap and services indices, but not in the S&P 500
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.